Association between serum homocysteine and markers of impaired kidney function in adults in the United States

被引:85
作者
Francis, ME
Eggers, PW
Hostetter, TH
Briggs, JP
机构
[1] NIDDK, KUH Div, NIH, Bethesda, MD 20892 USA
[2] Social & Sci Syst Inc, Silver Spring, MD USA
关键词
chronic kidney disease (CKD); cardiovascular disease; folate; B vitamins; NHANES;
D O I
10.1111/j.1523-1755.2004.00732.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Circulating homocysteine, a risk factor for cardiovascular disease (CVD), is often elevated in chronic kidney disease and end-stage renal disease (ESRD) patients. Little is known about the risk of elevated homocysteine associated with less advanced renal insufficiency in the community. Methods. Serum homocysteine concentration measures (umol/L) from the National Health and Nutrition Examination Survey (NHANES) 1991-1994 participants who were aged greater than or equal to40 years and fasted greater than or equal to6 hours (1558 men and 1829 women) were categorized as <9, 9 to 11.9, 12 to 14.9, and >= 15. Renal function levels were determined by Modified Diet in Renal Disease (MDRD) estimated glomerular filtration rate (GFRest) (mL/min/ 1.73 m(2)) and the urinary albumin-to-creatinine ratio (ACR) (mg/g). Cumulative odds ratios (OR) of exceeding any given homocysteine cut point were computed by gender, using ordinal logistic regression. Each model included GFRest (<60, 60 to 90, greater than or equal to90), ACR (<15, 15 to <30, greater than or equal to30), age, race/ethnicity, red blood cell folate, serum vitamin B-12, and dietary vitamin B-6 intake as independent variables. Results. The adjusted ORs for elevated homocysteine risk were 9 to 11 times greater in adults with the lowest GFRest levels (<60mL/min/1.73 m(2)) compared to those with normal GFRest levels. Association measures for marginal GFRest levels (60 to 90 mL/min/1.73 m(2)) were weaker but significant. Albuminuria (ACR >= 30 mg/g) was a significant, independent renal risk factor for elevated homocysteine in men and women (adjusted OR = 1.78, 95% CI 1.08-2.93, and adjusted OR = 1.83, 95% CI 1.21-2.76, respectively) relative to those with low normal albumin excretion, but high normal albuminuria (ACR = 15-30 mg/g) was not. Conclusion. In the general population, renal insufficiency is strongly associated with an increased risk of elevated circulating homocysteine, independent of B vitamin status. These results raise the possibility that elevated homocysteine may be an important risk factor to explain the heavy burden of CVD associated with kidney disease.
引用
收藏
页码:303 / 312
页数:10
相关论文
共 72 条
  • [1] *AGR RES SERV, 1995, SURV NUTR DAT NHANES
  • [2] Agresti A., 1990, Analysis of categorical data
  • [3] DETERMINATION OF FREE AND TOTAL HOMOCYSTEINE IN HUMAN-PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION
    ARAKI, A
    SAKO, Y
    [J]. JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1987, 422 : 43 - 52
  • [4] The effect of reduced glomerular filtration rate on plasma total homocysteine concentration
    Arnadottir, M
    Hultberg, B
    NilssonEhle, P
    Thysell, H
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1996, 56 (01) : 41 - 46
  • [5] BAILEY LB, 2001, PRESENT KNOWLEDGE NU, P214
  • [6] Does oral folic acid lower total homocysteine levels and improve endothelial function in children with chronic renal failure?
    Bennett-Richards, K
    Kattenhorn, M
    Donald, A
    Oakley, G
    Varghese, Z
    Rees, L
    Deanfield, JE
    [J]. CIRCULATION, 2002, 105 (15) : 1810 - 1815
  • [7] RENAL FUNCTIONAL RESERVE IN HUMANS - EFFECT OF PROTEIN-INTAKE ON GLOMERULAR-FILTRATION RATE
    BOSCH, JP
    SACCAGGI, A
    LAUER, A
    RONCO, C
    BELLEDONNE, M
    GLABMAN, S
    [J]. AMERICAN JOURNAL OF MEDICINE, 1983, 75 (06) : 943 - 950
  • [8] NET UPTAKE OF PLASMA HOMOCYSTEINE BY THE RAT-KIDNEY IN-VIVO
    BOSTOM, A
    BROSNAN, JT
    HALL, B
    NADEAU, MR
    SELHUB, J
    [J]. ATHEROSCLEROSIS, 1995, 116 (01) : 59 - 62
  • [9] Bostom AG, 1999, J AM SOC NEPHROL, V10, P891
  • [10] High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patients
    Bostom, AG
    Shemin, D
    Lapane, KL
    Hume, AL
    Yoburn, D
    Nadeau, MR
    Bendich, A
    Selhub, J
    Rosenberg, IH
    [J]. KIDNEY INTERNATIONAL, 1996, 49 (01) : 147 - 152